Innovative features and functionalities of an artificial pancreas system: What do youth and parents want?
Adolescent
Adult
Age Factors
Child
Diabetes Mellitus, Type 1
/ drug therapy
Equipment Design
/ psychology
Female
Humans
Insulin
/ administration & dosage
Insulin Infusion Systems
/ psychology
Interviews as Topic
Male
Middle Aged
Pancreas, Artificial
/ psychology
Parents
/ psychology
Patient Acceptance of Health Care
/ psychology
Patient Preference
Young Adult
artificial pancreas
children and adolescents
parents
patient preferences
system design
type 1 diabetes
young adults
Journal
Diabetic medicine : a journal of the British Diabetic Association
ISSN: 1464-5491
Titre abrégé: Diabet Med
Pays: England
ID NLM: 8500858
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
revised:
25
11
2020
received:
21
08
2020
accepted:
02
12
2020
pubmed:
9
12
2020
medline:
25
3
2022
entrez:
8
12
2020
Statut:
ppublish
Résumé
Participant-driven solutions may help youth and families better engage and maintain use of diabetes technologies. We explored innovative features and functionalities of an ideal artificial pancreas (AP) system suggested by youth with type 1 diabetes and parents. Semi-structured interviews were conducted with 39 youth, ages 10-25 years, and 44 parents. Interviews were recorded, transcribed and coded using thematic analysis. Youth (72% female, 82% non-Hispanic white) were (M ± SD) ages 17.0 ± 4.7 years, with diabetes for 9.4 ± 4.9 years, and HbA Youth and parents expressed creative solutions for an ideal AP system to increase ease of use, enhance normalcy, and reduce burden of management. Designers of AP systems will likely benefit from incorporating the desired preferences by end users to optimize acceptance and usability by young persons with diabetes.
Identifiants
pubmed: 33290599
doi: 10.1111/dme.14492
pmc: PMC9196947
mid: NIHMS1809944
doi:
Substances chimiques
Insulin
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14492Subventions
Organisme : NIDDK NIH HHS
ID : K12 DK094721
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK007260
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK036836
Pays : United States
Organisme : NIDDK NIH HHS
ID : DP3 DK113511
Pays : United States
Organisme : NIDDK NIH HHS
ID : DP3 DK104057
Pays : United States
Informations de copyright
© 2020 Diabetes UK.
Références
J Pediatr Psychol. 2020 Apr 1;45(3):247-265
pubmed: 31710671
Diabetes Educ. 2017 Apr;43(2):223-232
pubmed: 28340542
Diabetes Care. 2017 Nov;40(11):1453-1461
pubmed: 28842523
Diabetes Ther. 2020 Jun;11(6):1217-1235
pubmed: 32356245
J Diabetes Sci Technol. 2016 May 03;10(3):714-23
pubmed: 26589628
Lancet. 2017 Jan 28;389(10067):369-380
pubmed: 28007348
Diabetes Technol Ther. 2018 Mar;20(3):222-228
pubmed: 29565721
Diabetes Technol Ther. 2018 Jun;20(S2):S265-S268
pubmed: 29916739
Diabetes Technol Ther. 2020 Sep;22(9):645-650
pubmed: 31905008
Diabet Med. 2020 Nov;37(11):1832-1840
pubmed: 32298490
Diabetes Technol Ther. 2019 Feb;21(2):66-72
pubmed: 30657336
Lancet. 2019 Oct 5;394(10205):1265-1273
pubmed: 31533908
Diabetes Educ. 2008 Nov-Dec;34(6):1004-12
pubmed: 19075082
Diabetes Technol Ther. 2015 May;17(5):311-5
pubmed: 25629627
Diabetes Technol Ther. 2019 Mar;21(3):119-127
pubmed: 30720338
Health Serv Res. 1999 Dec;34(5 Pt 2):1189-208
pubmed: 10591279
Pediatr Diabetes. 2020 Mar;21(2):377-383
pubmed: 31808586
Qual Health Res. 2016 Apr;26(5):672-84
pubmed: 26893304